FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:490-495 February 18, 1993 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Gynecomastia, a benign enlargement of the male breast due to proliferation of the glandular component, is a common clinical condition. It may be an incidental finding on routine examination or may present as an acute unilateral or bilateral painful tender mass beneath the areolar region or as a progressive painless enlargement of the breast. This topic was last reviewed in the Journal in 1980,¹ and much of the recent literature has focused on the prevalence, pathogenesis, and treatment of the condition.

Prevalence

Palpable breast glandular tissue is so prevalent in population studies of men and boys^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15} (Table 1) that . . . [Full Text of this Article]

Conditions Associated with Gynecomastia

Pathogenesis

Increase in Serum Estrogen Concentrations

Decrease in Serum Androgen Concentrations

Androgen-Receptor Problems

Hypersensitive Breast Tissue

Evaluation

Treatment

Source Information

From the Department of Medicine, Cedars-Sinai Medical Center, and the UCLA School of Medicine, both in Los Angeles.

Address reprint requests to Dr. Braunstein at Cedars-Sinai Medical Center, 8700 Beverly Blvd., Rm. B118, Los Angeles, CA 90048.

References

Related Letters:

Gynecomastia
Malozowski S., Williams G. M., Braunstein G. D.
Extract | Full Text  
N Engl J Med 1993; 329:209, Jul 15, 1993. Correspondence

Botulism in a Pregnant Woman
Robin L., Herman D., Redett R.
Extract | Full Text  
N Engl J Med 1996; 335:823-824, Sep 12, 1996. Correspondence

This article has been cited by other articles:

• Czajka-Oraniec, I., Zgliczynski, W., Kurylowicz, A., Mikula, M., Ostrowski, J. (2008). Association between gynecomastia and aromatase (CYP19) polymorphisms. Eur J Endocrinol 158: 721-727 [Abstract] [Full Text]  
• Deonarain, J., Ramdial, P. K., Singh, B. (2008). Bilateral Lipomastia in Men: A Side Effect of Highly Active Antiretroviral Therapy. INT J SURG PATHOL 16: 171-175 [Abstract]  
• Shulman, D. I., Francis, G. L., Palmert, M. R., Eugster, E. A., for the Lawson Wilkins Pediatric Endocrine Society, (2008). Use of Aromatase Inhibitors in Children and Adolescents With Disorders of Growth and Adolescent Development. Pediatrics 121: e975-e983 [Abstract] [Full Text]  
• Braunstein, G. D. (2007). Gynecomastia. NEJM 357: 1229-1237 [Full Text]  
• Diamantopoulos, S., Bao, Y. (2007). Gynecomastia and Premature Thelarche: A Guide for Practitioners. Pediatr. Rev. 28: e57-e68 [Full Text]  
• Maratea, K. A., Ramos-Vara, J. A., Corriveau, L. A., Miller, M. A. (2007). Testicular Interstitial Cell Tumor and Gynecomastia in a Rabbit. Vet Pathol 44: 513-517 [Abstract] [Full Text]  
• Gardette, V., Vezzosi, D., Maiza, J.-C., Montastruc, J.-L., Olivier, P. (2007). Gynecomastia Associated with Fenofibrate. The Annals of Pharmacotherapy 41: 508-510 [Abstract] [Full Text]  
• Henley, D. V., Lipson, N., Korach, K. S., Bloch, C. A. (2007). Prepubertal Gynecomastia Linked to Lavender and Tea Tree Oils. NEJM 356: 479-485 [Abstract] [Full Text]  
• Chen, L., Chantra, P. K., Larsen, L. H., Barton, P., Rohitopakarn, M., Zhu, E. Q., Bassett, L. W. (2006). Imaging characteristics of malignant lesions of the male breast.. RadioGraphics 26: 993-1006 [Abstract] [Full Text]  
• Harris, M., Rizvi, S., Hindmarsh, J., Bryan, R. (2006). Testicular tumour presenting as gynaecomastia.. BMJ 332: 837-837 [Full Text]  
• Giordano, S. H. (2005). A Review of the Diagnosis and Management of Male Breast Cancer. The Oncologist 10: 471-479 [Abstract] [Full Text]  
• Karagiannis, A., Harsoulis, F. (2005). Gonadal dysfunction in systemic diseases. Eur J Endocrinol 152: 501-513 [Abstract] [Full Text]  
• Weiss, J. R., Moysich, K. B., Swede, H. (2005). Epidemiology of Male Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 14: 20-26 [Abstract] [Full Text]  
• Duong, M., Dinoulos, J. GH., Gupta, A., Bryk, T., Saps, M., Di Lorenzo, C., Sveen, A., Waseem, M., Kin, L. L. (2005). Index of Suspicion. Pediatr. Rev. 26: 23-33 [Full Text]  
• Plourde, P. V., Reiter, E. O., Jou, H.-C., Desrochers, P. E., Rubin, S. D., Bercu, B. B., Diamond, F. B. Jr., Backeljauw, P. F. (2004). Safety and Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial. J. Clin. Endocrinol. Metab. 89: 4428-4433 [Abstract] [Full Text]  
• Carlson, H. E., Kane, P., Lei, Z. M., Li, X., Rao, C. V. (2004). Presence of Luteinizing Hormone/Human Chorionic Gonadotropin Receptors in Male Breast Tissues. J. Clin. Endocrinol. Metab. 89: 4119-4123 [Abstract] [Full Text]  
• Rosen, D. S. (2004). Physiologic Growth and Development During Adolescence. Pediatr. Rev. 25: 194-200 [Full Text]  
• Hanneken, S., Kruse, R., Dall, P., Ruzicka, T., Neumann, N. J. (2004). Unilateral Pseudogynecomastia: A Novel Work-Related Disease. ANN INTERN MED 140: W-28-W-28 [Full Text]  
• Giordano, S. H., Buzdar, A. U., Hortobagyi, G. N. (2002). Breast Cancer in Men. ANN INTERN MED 137: 678-687 [Abstract] [Full Text]  
• (2001). Abstracts. J Oncol Pharm Pract 7: 55-106  
• Hayes, F. J., Eichhorn, J. H. (2000). Case 12-2000- A 60-Year-Old Man with Persistent Gynecomastia after Excision of a Pituitary Adenoma. NEJM 342: 1196-1204 [Full Text]  
• Dobs, A. S., Meikle, A. W., Arver, S., Sanders, S. W., Caramelli, K. E., Mazer, N. A. (1999). Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men. J. Clin. Endocrinol. Metab. 84: 3469-3478 [Abstract] [Full Text]  
• Drop, S. L. S., de Waal, W. J., de Muinck Keizer-Schrama, S. M. P. F. (1998). Sex Steroid Treatment of Constitutionally Tall Stature. Endocr. Rev. 19: 540-558 [Abstract] [Full Text]  
• Sher, E. S., Migeon, C. J., Berkovitz, G. D. (1998). Evaluation of Boys with Marked Breast Development at Puberty. CLIN PEDIATR 37: 367-371 [Abstract]  
• Stratakis, C. A., Vottero, A., Brodie, A., Kirschner, L. S., DeAtkine, D., Lu, Q., Yue, W., Mitsiades, C. S., Flor, A. W., Chrousos, G. P. (1998). The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription. J. Clin. Endocrinol. Metab. 83: 1348-1357 [Abstract] [Full Text]  
• Green, L., Wysowski, D. K., Fourcroy, J. L. (1996). Gynecomastia and Breast Cancer during Finasteride Therapy. NEJM 335: 823-823 [Full Text]  
• Rodriguez, L A G., Jick, H (1994). Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 308: 503-506 [Abstract] [Full Text]  
• Malozowski, S., Williams, G. M., Braunstein, G. D. (1993). Gynecomastia. NEJM 329: 209-209 [Full Text]